Client Appointment

Midatech Pharma Appointment

22
Mar

IFC Advisory is delighted to be working with Midatech Pharma (LSE AIM: MTPH; NASDAQ: MTP) Midatech is an R&D company focused on delivering innovative oncology and rare disease products to patients. The Company is developing a range of improved chemo-therapeutics or new immuno-therapeutics, using its three-proprietary platform drug delivery technologies, all of which are in the clinic.

Dec 2025 – IFC advises on $2.4bn takeover of Alphawave Semi

IFC advises on $2.4bn takeover of Alphawave Semi

31
Dec
Nov 2025 – IFC advises on £35m Zotefoams acquisition of OKC

IFC advises on £35m Zotefoams acquisition of OKC

30
Nov
Nov 2025 – Ethtry plc appoints IFC

Ethtry plc appoints IFC

30
Nov
IFC Advisory
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.